An assessment of histone-modification antibody quality

Department of Molecular, Cell and Developmental Biology, University of California Santa Cruz, Santa Cruz, California, USA.
Nature Structural & Molecular Biology (Impact Factor: 13.31). 01/2011; 18(1):91-3. DOI: 10.1038/nsmb.1972
Source: PubMed


We have tested the specificity and utility of more than 200 antibodies raised against 57 different histone modifications in Drosophila melanogaster, Caenorhabditis elegans and human cells. Although most antibodies performed well, more than 25% failed specificity tests by dot blot or western blot. Among specific antibodies, more than 20% failed in chromatin immunoprecipitation experiments. We advise rigorous testing of histone-modification antibodies before use, and we provide a website for posting new test results (

Download full-text


Available from: David Hawkins,
  • Source
    • "To this aim, we have developed a collection of native and engineered histone modification interaction domains (HMIDs), which strongly and specifically interact with H3 tails methylated at different lysine residues. The most promising domains were investigated with respect to the primary and secondary ENCODE criteria for antibody validation, such as specificity in Western blotting with native, recombinant, and PTM-depleted histones, binding to modified peptides, and ChIP-like experiments (Egelhofer et al. 2011; Landt et al. 2012). In all our experiments, the efficiency of HMIDs was directly compared side-by-side with popular commercial antibodies recognizing the same PTMs. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Post-translational modifications (PTMs) of histones constitute a major chromatin indexing mechanism, and their proper characterization is of highest biological importance. So far, PTM-specific antibodies have been the standard reagent for studying histone PTMs despite caveats such as lot-to-lot variability of specificity and binding affinity. Herein, we successfully employed naturally occurring and engineered histone modification interacting domains for detection and identification of histone PTMs and ChIP-like enrichment of different types of chromatin. Our results demonstrate that histone interacting domains are robust and highly specific reagents that can replace or complement histone modification antibodies. These domains can be produced recombinantly in Escherichia coli at low cost and constant quality. Protein design of reading domains allows for generation of novel specificities, addition of affinity tags, and preparation of PTM binding pocket variants as matching negative controls, which is not possible with antibodies.
    Genome Research 10/2014; DOI:10.1101/gr.170985.113 · 14.63 Impact Factor
  • Source
    • "A second independent challenge for contemporary ChIP-seq experiments is that the supply of high-quality sustainable immune reagents that have been experimentally validated for ChIP remains very limited. Many antibodies, including some marketed as “ChIP-grade” have failed in the ENCODE pipeline, and many that have succeeded are polyclonal, which means that different lots can vary radically in how well they perform in ChIP23. At present, monoclonal antibodies are the most reliable renewable ChIP reagents, although they do not account for the majority of characterized reagents, and there are no ChIP-competent reagents for the majority of human and mouse transcription factors. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Chromatin immunoprecipitation coupled with DNA sequencing (ChIP-seq) is the major contemporary method for mapping in vivo protein-DNA interactions in the genome. It identifies sites of transcription factor, cofactor and RNA polymerase occupancy, as well as the distribution of histone marks. Consortia such as the ENCyclopedia Of DNA Elements (ENCODE) have produced large datasets using manual protocols. However, future measurements of hundreds of additional factors in many cell types and physiological states call for higher throughput and consistency afforded by automation. Such automation advances, when provided by multiuser facilities, could also improve the quality and efficiency of individual small-scale projects. The immunoprecipitation process has become rate-limiting, and is a source of substantial variability when performed manually. Here we report a fully automated robotic ChIP (R-ChIP) pipeline that allows up to 96 reactions. A second bottleneck is the dearth of renewable ChIP-validated immune reagents, which do not yet exist for most mammalian transcription factors. We used R-ChIP to screen new mouse monoclonal antibodies raised against p300, a histone acetylase, well-known as a marker of active enhancers, for which ChIP-competent monoclonal reagents have been lacking. We identified, validated for ChIP-seq, and made publicly available a monoclonal reagent called ENCITp300-1.
    Scientific Reports 06/2014; 4:5152. DOI:10.1038/srep05152 · 5.58 Impact Factor
  • Source
    • "H3K27me3 genome profiles during late development of ovine skeletal muscle ChIP-Seq, using a specific antibody to H3K27me3, was performed on ovine LL skeletal muscle (n = 3/gp) sampled at 100 days of gestation (foetus) and 12 weeks of age (lamb) (Bock et al. 2010; Egelhofer et al. 2011). Input nucleosomal DNA, prepared by micrococcal nuclease (MNase) digestion of isolated chromatin, was characterised by a ~150-bp band representing MNase-protected DNA (147 bp) wrapped around the histone octamer (Fig. S1) (Luger et al. 1997). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The ruminant developmental transition from late foetus to lamb is associated with marked changes in skeletal muscle structure and function that reflect programming for new physiological demands following birth. To determine whether epigenetic changes are involved in this transition, we investigated the genomic architecture of the chromatin modification, histone 3 lysine 27 trimethylation (H3K27me3), which typically regulates early life developmental processes; however, its role in later life processes is unclear. Chromatin immunoprecipitation coupled with next-generation sequencing was used to map H3K27me3 nucleosomes in ovine longissimus lumborum skeletal muscle at 100 days of gestation and 12 weeks post-partum. In both states, H3K27me3 modification was associated with genes, transcription start sites and CpG islands and with transcriptional silencing. The H3K27me3 peaks consisted of two major categories, promoter specific and regional, with the latter the dominant feature. Genes encoding homeobox transcription factors regulating early life development and genes involved in neural functions, particularly gated ion channels, were strongly modified by H3K27me3. Gene promoters differentially modified by H3K27me3 in the foetus and lamb were enriched for gated ion channels, which may reflect changes in neuromuscular function. However, most modified genes showed no changes, indicating that H3K27me3 does not have a large role in late muscle maturation. Notably, promyogenic transcription factors were strongly modified with H3K27me3 but showed no differences between the late gestation foetus and lamb, likely reflecting their lack of involvement in the myofibre fusion process occurring in this transition. H3K27me3 is a major architectural feature of the epigenetic landscape of ruminant skeletal muscle, and it comments on gene transcription and gene function in the context of late skeletal muscle development.
    Animal Genetics 03/2014; 45(3). DOI:10.1111/age.12145 · 2.21 Impact Factor
Show more